Deutsche Bank’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $210K | Hold |
525,353
| – | – | ﹤0.01% | 2933 |
|
|
2025
Q1 | $184K | Hold |
525,353
| – | – | ﹤0.01% | 2962 |
|
|
2024
Q4 | $310K | Hold |
525,353
| – | – | ﹤0.01% | 2854 |
|
|
2024
Q3 | $925K | Sell |
525,353
-670,000
| -56% | -$1.18M | ﹤0.01% | 2118 |
|
|
2024
Q2 | $1.64M | Sell |
1,195,353
-48,894
| -4% | -$67K | ﹤0.01% | 1713 |
|
|
2024
Q1 | $4.28M | Buy |
1,244,247
+119,044
| +11% | +$410K | ﹤0.01% | 1321 |
|
|
2023
Q4 | $2.77M | Buy |
1,125,203
+846,081
| +303% | +$2.08M | ﹤0.01% | 1494 |
|
|
2023
Q3 | $475K | Sell |
279,122
-413,268
| -60% | -$703K | ﹤0.01% | 2184 |
|
|
2023
Q2 | $2.08M | Hold |
692,390
| – | – | ﹤0.01% | 1600 |
|
|
2023
Q1 | $1.86M | Buy |
692,390
+293,771
| +74% | +$787K | ﹤0.01% | 1727 |
|
|
2022
Q4 | $3.29M | Buy |
398,619
+100,000
| +33% | +$825K | ﹤0.01% | 1398 |
|
|
2022
Q3 | $2.3M | Buy |
298,619
+150,000
| +101% | +$1.15M | ﹤0.01% | 1557 |
|
|
2022
Q2 | $424K | Sell |
148,619
-32,938
| -18% | -$94K | ﹤0.01% | 2694 |
|
|
2022
Q1 | $908K | Sell |
181,557
-925
| -0.5% | -$4.63K | ﹤0.01% | 2402 |
|
|
2021
Q4 | $3.58M | Sell |
182,482
-2,159
| -1% | -$42.4K | ﹤0.01% | 1623 |
|
|
2021
Q3 | $5.44M | Sell |
184,641
-187,970
| -50% | -$5.53M | ﹤0.01% | 1453 |
|
|
2021
Q2 | $15.8M | Buy |
372,611
+364,924
| +4,747% | +$15.5M | 0.01% | 992 |
|
|
2021
Q1 | $391K | Buy |
+7,687
| New | +$391K | ﹤0.01% | 3231 |
|